1.0PNHPhttps://pnhp.orgpnhpf3ahttps://pnhp.org/author/pnhpf3a/New drugs fail to align benefits, risks and costs - PNHPrich600338<blockquote class="wp-embedded-content"><a href="https://pnhp.org/news/new-drugs-fail-to-align-benefits-risks-and-costs/">New drugs fail to align benefits, risks and costs</a></blockquote>
<script type='text/javascript'>
<!--//--><![CDATA[//><!--
/**
* WordPress inline HTML embed
*
* @since 4.4.0
* @output wp-includes/js/wp-embed.js
*
* This file cannot have ampersands in it. This is to ensure
* it can be embedded in older versions of WordPress.
* See https://core.trac.wordpress.org/changeset/35708.
*/
(function ( window, document ) {
'use strict';
var supportedBrowser = false,
loaded = false;
if ( document.querySelector ) {
if ( window.addEventListener ) {
supportedBrowser = true;
}
}
/** @namespace wp */
window.wp = window.wp || {};
if ( !! window.wp.receiveEmbedMessage ) {
return;
}
window.wp.receiveEmbedMessage = function( e ) {
var data = e.data;
if ( ! data ) {
return;
}
if ( ! ( data.secret || data.message || data.value ) ) {
return;
}
if ( /[^a-zA-Z0-9]/.test( data.secret ) ) {
return;
}
var iframes = document.querySelectorAll( 'iframe[data-secret="' + data.secret + '"]' ),
blockquotes = document.querySelectorAll( 'blockquote[data-secret="' + data.secret + '"]' ),
i, source, height, sourceURL, targetURL;
for ( i = 0; i < blockquotes.length; i++ ) {
blockquotes[ i ].style.display = 'none';
}
for ( i = 0; i < iframes.length; i++ ) {
source = iframes[ i ];
if ( e.source !== source.contentWindow ) {
continue;
}
source.removeAttribute( 'style' );
/* Resize the iframe on request. */
if ( 'height' === data.message ) {
height = parseInt( data.value, 10 );
if ( height > 1000 ) {
height = 1000;
} else if ( ~~height < 200 ) {
height = 200;
}
source.height = height;
}
/* Link to a specific URL on request. */
if ( 'link' === data.message ) {
sourceURL = document.createElement( 'a' );
targetURL = document.createElement( 'a' );
sourceURL.href = source.getAttribute( 'src' );
targetURL.href = data.value;
/* Only continue if link hostname matches iframe's hostname. */
if ( targetURL.host === sourceURL.host ) {
if ( document.activeElement === source ) {
window.top.location.href = data.value;
}
}
}
}
};
function onLoad() {
if ( loaded ) {
return;
}
loaded = true;
var isIE10 = -1 !== navigator.appVersion.indexOf( 'MSIE 10' ),
isIE11 = !!navigator.userAgent.match( /Trident.*rv:11\./ ),
iframes = document.querySelectorAll( 'iframe.wp-embedded-content' ),
iframeClone, i, source, secret;
for ( i = 0; i < iframes.length; i++ ) {
source = iframes[ i ];
if ( ! source.getAttribute( 'data-secret' ) ) {
/* Add secret to iframe */
secret = Math.random().toString( 36 ).substr( 2, 10 );
source.src += '#?secret=' + secret;
source.setAttribute( 'data-secret', secret );
}
/* Remove security attribute from iframes in IE10 and IE11. */
if ( ( isIE10 || isIE11 ) ) {
iframeClone = source.cloneNode( true );
iframeClone.removeAttribute( 'security' );
source.parentNode.replaceChild( iframeClone, source );
}
}
}
if ( supportedBrowser ) {
window.addEventListener( 'message', window.wp.receiveEmbedMessage, false );
document.addEventListener( 'DOMContentLoaded', onLoad, false );
window.addEventListener( 'load', onLoad, false );
}
})( window, document );
//--><!]]>
</script><iframe sandbox="allow-scripts" security="restricted" src="https://pnhp.org/news/new-drugs-fail-to-align-benefits-risks-and-costs/embed/" width="600" height="338" title="“New drugs fail to align benefits, risks and costs” — PNHP" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe>Serious Risks And Few New Benefits From FDA-Approved DrugsBy Donald W. LightHealth Affairs Blog, July 6, 2015Over the past year, the U.S. Senate and The New York Times have been investigating the failure of the nation’s auto safety regulators to protect citizens from cars with occasionally dangerous faulty devices.Outrageously high pricing is not the only problem we face with new pharmaceutical products. We are inundated with new drugs that provide little or no improvement over existing products. This exposes us not only to the higher prices driven by new patents, but also to the potential of serious adverse effects that may not be recognized until the new drugs have been on the market for a period of time.